Increasing marginal utility of small increases in life-expectancy? Results from a population survey

Journal of Health Economics

Volumn 29, Issue 4, 2010, Pages 541-548

  Kvamme, Maria Knoph ^a   Gyrd Hansen, Dorte ^b,c   Olsen, Jan Abel ^a,d   Kristiansen, Ivar Sønbø ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Dansk Sundhedsinstitut   (Denmark)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cost effectiveness methodology; Linear models; Willingness to pay

Indexed keywords

HEALTH CARE; LIFE EXPECTANCY; LINEARITY; MODELING; WILLINGNESS TO PAY;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; LIFE EXTENSION; LINEAR SYSTEM; MALE; NORWAY; POPULATION RESEARCH; STATISTICAL MODEL; ATTITUDE TO HEALTH; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; MIDDLE AGED; NONLINEAR SYSTEM; PATIENT ATTITUDE; PATIENT PREFERENCE; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ADULT; ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PREFERENCE; QUESTIONNAIRES;

NORWAY;

EID: 77954658743     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2010.03.010     Document Type: Article

References (23)

1. Abdellaoui M., Barrios C., Wakker P.P. Reconciling introspective utility with revealed preference: experimental arguments based on prospect theory. Journal of Econometrics 2007, 138(1):356-378.
2. Abellán-Perpiñán J.-M., Pinto-Prades José-Luis, Méndez-Martínez I., Badía-Llach X. Towards a better QALYmodel. Health Economics 2006, 15:665-676.
3. Bleichrodt H., Doctor J., Stolk E. A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. Journal of Health Economics 2005, 24(4):655-678.
4. Bleichrodt H., Pinto J.L. A parameter-free elicitation of the probability weighting function in medical decision analysis. Management Science 2000, 46(11):1485.
5. Bleichrodt H., van Rijn J., Johannesson M. Probability weighting and utility curvature in QALY-based decision making. Journal of Mathematical Psychology 1999, 43(2):238-260.
6. Dahl R., Gyrd-Hansen D., Kristiansen I., Nexoe J., Bo Nielsen J. Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. BMC Medical Informatics and Decision Making 2007, 7(1):8.
7. Doctor J.N., Bleichrodt H., Miyamoto J., Temkin N.R., Dikmen S. A new and more robust test of QALYs. Journal of Health Economics 2004, 23(2):353-367.
8. Doctor J.N., Miyamoto J.M. Deriving quality-adjusted life years (QALYs) from constant proportional time tradeoff and risk posture conditions. Journal of Mathematical Psychology 2003, 47(5-6):557-567.
9. Dolan P., Shaw R., Tsuchiya A., Williams A. QALY maximisation and people's preferences: a methodological review of the literature 22. Health Economics 2005, 14(2):197-208.
10. Dolan P., Jones-Lee M. The time trade-off: a note on the effect of lifetime reallocation of consumption and discounting. Journal of Health Economics 1997, 16(6):731-739.
11. Gyrd-Hansen D., Kristiansen I.S. Preferences for 'life-saving' programmes: small for all or gambling for the prize?. Health Economics 2007, 17(6):709-720.
12. Johannesson M., Pliskin J.S., Weinstein M.C. A note on QALYs, time tradeoff, and discounting. Medical Decision Making 1994, 14:188-193.
13. Kristiansen I.S., Gyrd-Hansen D., Nexoe J., Nielsen J.B. Number needed to treat: easily understood and intuitively meaningful?: theoretical considerations and a randomized trial. Journal of Clinical Epidemiology 2002, 55(9):888-892.
14. Kristiansen I.S., Gyrd-Hansen D. Communicating treatment effectiveness in the context of chronic disease processes. Expert Review of Pharmacoeconomics & Outcomes Research 2006, 6(6):673-679.
15. Miyamoto J.M., Eraker A. Parameter estimates for a QALY utility model. Medical Decision Making 1985, 5:191.
16. Miyamoto J.M., Eraker S.A. A multiplicative model of the utility of survival duration and health quality. Journal of Experimental Psychology: General 1988, 117(1):3-20.
17. Moore M.J., Kip Viscusi W. Models for estimating discount rates for long-term health risks using labor market data. Journal of Risk and Uncertainty 1990, 3(4):381-401.
18. Olsen J.A. A note on eliciting distributive preferences for health. Journal of Health Economics 2000, 19(4):541-550.
19. Pliskin J.S., Shepard D.S., Weinstein M.C. Utility functions for life years and health status. Operations Research 1980, 28:206-224.
20. Rodriguez-Miguez E., Pinto-Prades J.L. Measuring the social importance of concentration or dispersion of individual health benefits. Health Economics 2002, 11(1):43-53.
21. Saha A. Expo-power utility: a flexible form for absolute and relative risk aversion. American Journal of Agricultural Economics 1993, 75(4):905-913.
22. Stiggelbout A.M., Kiebert G.M., Kievit J., Leer J.W.H., Stoter G., De Haes J.C.J.M. Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores. Medical Decision Making 1994, 14(1):82-90.
23. Wright J.C., Weinstein M.C. Gains in life expectancy from medical interventions-standardizing data on outcomes. New England Journal of Medicine 1998, 339(6):380-386.